These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

611 related articles for article (PubMed ID: 32521450)

  • 21. Nobiletin Ameliorates Hepatic Lipid Deposition, Oxidative Stress, and Inflammation by Mechanisms That Involve the Nrf2/NF-κB Axis in Nonalcoholic Fatty Liver Disease.
    Fan C; Ling-Hu A; Sun D; Gao W; Zhang C; Duan X; Li H; Tian W; Yu Q; Ke Z
    J Agric Food Chem; 2023 Dec; 71(50):20105-20117. PubMed ID: 38073108
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chrysin ameliorates nonalcoholic fatty liver disease in rats.
    Pai SA; Munshi RP; Panchal FH; Gaur IS; Juvekar AR
    Naunyn Schmiedebergs Arch Pharmacol; 2019 Dec; 392(12):1617-1628. PubMed ID: 31372694
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term subcutaneous injection of lipopolysaccharides and high-fat diet induced non-alcoholic fatty liver disease through IKKε/ NF-κB signaling.
    He Q; Zeng J; Yao K; Wang W; Wu Q; Tang R; Xia X; Zou X
    Biochem Biophys Res Commun; 2020 Nov; 532(3):362-369. PubMed ID: 32883523
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Polysaccharide of Atractylodes macrocephala Koidz alleviates NAFLD-induced hepatic inflammation in mice by modulating the TLR4/MyD88/NF-κB pathway.
    Chen J; Yang S; Luo H; Fu X; Li W; Li B; Fu C; Chen F; Xu D; Cao N
    Int Immunopharmacol; 2024 Nov; 141():113014. PubMed ID: 39191120
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The chloroform extract of Cyclocarya paliurus attenuates high-fat diet induced non-alcoholic hepatic steatosis in Sprague Dawley rats.
    Lin Z; Wu ZF; Jiang CH; Zhang QW; Ouyang S; Che CT; Zhang J; Yin ZQ
    Phytomedicine; 2016 Nov; 23(12):1475-1483. PubMed ID: 27765368
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NLRP3 inhibitor glibenclamide attenuates high-fat diet and streptozotocin-induced non-alcoholic fatty liver disease in rat: studies on oxidative stress, inflammation, DNA damage and insulin signalling pathway.
    Dwivedi DK; Jena GB
    Naunyn Schmiedebergs Arch Pharmacol; 2020 Apr; 393(4):705-716. PubMed ID: 31834465
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Carnosic acid protects mice from high-fat diet-induced NAFLD by regulating MARCKS.
    Song HM; Li X; Liu YY; Lu WP; Cui ZH; Zhou L; Yao D; Zhang HM
    Int J Mol Med; 2018 Jul; 42(1):193-207. PubMed ID: 29620148
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Curcumin Ameliorates Nonalcoholic Fatty Liver Disease through Inhibition of
    Lee DE; Lee SJ; Kim SJ; Lee HS; Kwon OS
    Nutrients; 2019 Nov; 11(11):. PubMed ID: 31717261
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-inflammatory activity of berberine in non-alcoholic fatty liver disease via the Angptl2 pathway.
    Lu Z; He B; Chen Z; Yan M; Wu L
    BMC Immunol; 2020 May; 21(1):28. PubMed ID: 32429849
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rotundic acid ameliorates non-alcoholic steatohepatitis via SREBP-1c/ SCD1 signaling pathway and modulating gut microbiota.
    Liu HJ; Cao ST; Wen BY; Han X; Li Y; Li S; Li J; Zhang L
    Int Immunopharmacol; 2021 Oct; 99():108065. PubMed ID: 34426119
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protective Effect of Fuzi Lizhong Decoction against Non-alcoholic Fatty Liver Disease via Anti-inflammatory Response through Regulating p53 and PPARG Signaling.
    Yang J; Ma W; Mei Q; Song J; Shu L; Zhang S; Li C; An L; Du N; Shi Z
    Biol Pharm Bull; 2020; 43(11):1626-1633. PubMed ID: 33132309
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Icariin alleviates high-fat diet-induced nonalcoholic fatty liver disease via up-regulating miR-206 to mediate NF-κB and MAPK pathways.
    Zhao H; Tian H
    J Biochem Mol Toxicol; 2024 Jan; 38(1):e23566. PubMed ID: 37888945
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Li-Gan-Shi-Liu-Ba-Wei-San improves non-alcoholic fatty liver disease through enhancing lipid oxidation and alleviating oxidation stress.
    Jiang Y; Chen L; Wang H; Narisi B; Chen B
    J Ethnopharmacol; 2015 Dec; 176():499-507. PubMed ID: 26571089
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Naringenin reduces cholesterol-induced hepatic inflammation in rats by modulating matrix metalloproteinases-2, 9 via inhibition of nuclear factor κB pathway.
    Chtourou Y; Fetoui H; Jemai R; Ben Slima A; Makni M; Gdoura R
    Eur J Pharmacol; 2015 Jan; 746():96-105. PubMed ID: 25446569
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Zhimu-Huangbai herb-pair ameliorates hepatic steatosis in mice by regulating IRE1α/XBP1s pathway to inhibit SREBP-1c.
    Zhao W; Wang X; Nie W; Jiang M; Zhao Y; Zhang T; Ding Y
    Phytomedicine; 2024 Nov; 134():156017. PubMed ID: 39265443
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chinese herb extract improves liver steatosis by promoting the expression of high molecular weight adiponectin in NAFLD rats.
    Liu X; Tong W; Zhao X; Zhang H; Tang Y; Deng X
    Mol Med Rep; 2017 Oct; 16(4):5580-5586. PubMed ID: 28849192
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effect of soothing liver and invigorating spleen recipes on SREBP-1c mRNA and protein expression in hepatic tissues of rats with non-alcoholic fatty liver disease].
    He XM; Yang QH; Li PF; Chen Z; Feng GF; Wang WJ; Liu HT; Zhang YP; Ji GY
    Zhong Yao Cai; 2011 Jun; 34(6):931-7. PubMed ID: 22017010
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Wuzhi capsule (Schisandra Sphenanthera extract) attenuates liver steatosis and inflammation during non-alcoholic fatty liver disease development.
    Chen Z; Liu F; Zheng N; Guo M; Bao L; Zhan Y; Zhang M; Zhao Y; Guo W; Ding G
    Biomed Pharmacother; 2019 Feb; 110():285-293. PubMed ID: 30522014
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dimethyl fumarate reduces oxidative stress, inflammation and fat deposition by modulation of Nrf2, SREBP-1c and NF-κB signaling in HFD fed mice.
    Vanani AR; Kalantari H; Mahdavinia M; Rashno M; Khorsandi L; Khodayar MJ
    Life Sci; 2021 Oct; 283():119852. PubMed ID: 34332979
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Jiangzhi Ligan Decoction Inhibits GSDMD-Mediated Canonical/Noncanonical Pyroptosis Pathways and Alleviates High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease.
    Yin K; Zhou X; Jiang W; Wang L; Dai Z; Tang B
    Dis Markers; 2021; 2021():9963534. PubMed ID: 34239622
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.